Nevertheless, a prospective study not included in this review identified TG-based aPC-r as a higher risk factor for thrombosis in a population of patients with APS and/or SLE and aPL carriers, compared to the traditional Sydney criteria aPL (33). The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.